188 East Blaine Street Suite 400 Seattle, WA 98102 sana.com
Note: Revenues for privately held companies are statistical evaluations.
Sana Biotechnology's annual revenues are $100-$500 million (see exact revenue data) and has 100-500 employees. It is classified as operating in the Scientific Research & Development Services industry.
Sana Biotechnology's Annual Report & Profile shows critical firmographic facts:
What is the company's size? (Annual sales and employees)
Note: Sana Biotechnology's revenues are gauged from an analysis of company filings.
Investor Activity
Sana Biotechnology has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
June 26, 2020
8
100%
$46 MM
Complete list of funding rounds and total amounts in the Company Report
Sana Biotechnology's Income Statement (based on Industry Averages)
$ Millions (Industry Average)
Sana Biotechnology Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Trademark Applications
Trademark applications show the products and services that Sana Biotechnology is developing and marketing.
Sana Biotechnology doesn't have any recent trademark applications, indicating Sana Biotechnology is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
SANA BIOTECHNOLOGY Cells for medical or clinical purposes; pharmaceutical preparations for cell therapy for medical or clinical purposes; pharmaceutical preparations for gene therapy for medical or clinical purposes; kits comprised of cells and pharmaceutical preparations for medical or clinical purposes
08/16/2018
See all trademarks and details in the Full Report.
Recession Risk
Determine whether Sana Biotechnology grew or shrank during the last recession. This is useful in estimating the
financial strength and credit risk of the company.
Compare how recession-proof Sana Biotechnology is relative to the industry overall.
While a new recession may strike a particular industry, measuring the
industry and company's robustness during the last recession estimates its ability to weather future recessions.
Market Share of Sana Biotechnology's Largest Competitors
A competitive analysis shows these companies are in the same general field as Sana Biotechnology, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Sana Biotechnology.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
Future Competition: Sana Biotechnology's Fastest Growing Competitors
These companies are in the same general field as Sana Biotechnology and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.